240 related articles for article (PubMed ID: 16629702)
1. Immunohistological features of visceral leishmaniasis in BALB/c mice.
Carrión J; Nieto A; Iborra S; Iniesta V; Soto M; Folgueira C; Abanades DR; Requena JM; Alonso C
Parasite Immunol; 2006 May; 28(5):173-83. PubMed ID: 16629702
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
3. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
Rosypal AC; Zajac AM; Troy GC; Lindsay DS
Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis.
Agallou M; Smirlis D; Soteriadou KP; Karagouni E
Vaccine; 2012 Jul; 30(34):5086-93. PubMed ID: 22704924
[TBL] [Abstract][Full Text] [Related]
5. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice.
Rafati S; Zahedifard F; Azari MK; Taslimi Y; Taheri T
Exp Parasitol; 2008 Mar; 118(3):393-401. PubMed ID: 18093586
[TBL] [Abstract][Full Text] [Related]
6. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
Agallou M; Margaroni M; Karagouni E
Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
[TBL] [Abstract][Full Text] [Related]
7. Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge.
Ferrua B; Luci C; Le Fichoux Y; Paul A; Marty P
Vaccine; 2006 Jan; 24(5):589-96. PubMed ID: 16157427
[TBL] [Abstract][Full Text] [Related]
8. The importance of TGF-beta in murine visceral leishmaniasis.
Wilson ME; Young BM; Davidson BL; Mente KA; McGowan SE
J Immunol; 1998 Dec; 161(11):6148-55. PubMed ID: 9834100
[TBL] [Abstract][Full Text] [Related]
9. Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis.
Gangneux JP; Chau F; Sulahian A; Derouin F; Garin YJ
Eur Cytokine Netw; 1999 Dec; 10(4):557-9. PubMed ID: 10586123
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
11. Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniasis in chronically infected BALB/c mice.
Rousseau D; Suffia I; Ferrua B; Philip P; Le Fichoux Y; Kubar JL
Eur Cytokine Netw; 1998 Dec; 9(4):655-61. PubMed ID: 9889410
[TBL] [Abstract][Full Text] [Related]
12. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
Paul J; Karmakar S; De T
Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
[TBL] [Abstract][Full Text] [Related]
13. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
14. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells.
Carrión J; Folgueira C; Alonso C
Vaccine; 2008 May; 26(20):2537-44. PubMed ID: 18400342
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA
Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response.
Rosa R; Marques C; Rodrigues OR; Santos-Gomes GM
Vaccine; 2007 Jun; 25(23):4525-32. PubMed ID: 17478016
[TBL] [Abstract][Full Text] [Related]
17. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
Khoshgoo N; Zahedifard F; Azizi H; Taslimi Y; Alonso MJ; Rafati S
Vaccine; 2008 Oct; 26(46):5822-9. PubMed ID: 18804512
[TBL] [Abstract][Full Text] [Related]
18. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
Pirdel L; Farajnia S
Scand J Immunol; 2017 Jul; 86(1):15-22. PubMed ID: 28426153
[TBL] [Abstract][Full Text] [Related]
19. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
[TBL] [Abstract][Full Text] [Related]
20. Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice.
Gomes DC; Pinto EF; de Melo LD; Lima WP; Larraga V; Lopes UG; Rossi-Bergmann B
Vaccine; 2007 Mar; 25(12):2168-72. PubMed ID: 17240003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
